「et」の検索結果
129件：16～20件目を表示
-
R&D Pipeline | Research & Development | SENJU Pharmaceutica
tion after Phase 1 DrugIndicationStatus (Region) PranoprofeninflammationApplication under review (Vietnam) SJP-0135GlaucomaApproval（Japan） SJP-0132Dry eyeApplication under review（Japan） SJP-0132Dry ey...
http://www.senju.co.jp/english/rd/pipeline.html -
お知らせ | 千寿製薬株式会社
September 4, 2025 Senju has developed and obtained approval for a BAC-free formulation of Aibeta® combination eye drops（PDF） March 7, 2025 Announcement of Licensing Agreement with Brill International（...
http://www.senju.co.jp/english/news/ -
Quality Policies | About Senju | SENJU Pharmaceutical
We will set the following "Quality Policies" and continue to be a "Good Company" by encouraging cooperation among all employees and providing high-quality products for "realiz...
http://www.senju.co.jp/english/about/quality.html -
Presence of Products | Overseas Activities | SENJU Pharmaceutical
Asia Middle East Europe North&South Ameica Asia India Brand Name Marketing Authorisation Holder JP Brand Name GLUCOTIM－LA Centaur Pharmaceuticals PVT LTD Not marketed in JP Korea Brand Name Market...
http://www.senju.co.jp/english/global/world.html -
Overseas Activities | SENJU Pharmaceutical
a, we established a local subsidiary, Jiangsu Senju Pharmaceutical Co., Ltd., to strengthen our marketing system and steadily lay the groundwork for globalization. Overseas bases BEIJING OFFICEBeijing...
http://www.senju.co.jp/english/global/